Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
- PMID: 12816821
- PMCID: PMC162124
- DOI: 10.1136/bmj.326.7403.1358
Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis
Abstract
Objectives: To evaluate the haematological findings of patients with severe acute respiratory syndrome (SARS).
Design: Analysis of the demographic, clinical, and laboratory characteristics of patients with SARS.
Setting: Prince of Wales Hospital, Hong Kong. Subjects All patients with a diagnosis of SARS between 11 March and 29 March 2003 who had no pre-existing haematological disorders.
Main outcome measures: Clinical end points included the need for intensive care and death. Univariate and multivariate analyses were performed to examine factors associated with adverse outcome.
Results: 64 male and 93 female patients were included in this study. The most common findings included lymphopenia in 153 (98%) of the 157 patients, neutrophilia in 129 (82%), thrombocytopenia in 87 patients (55%), followed by thrombocytosis in 77 (49%), and isolated prolonged activated partial thromboplastin time in 96 patients (63%). The haemoglobin count dropped by more than 20 g/l from baseline in 95 (61%) patients. Four patients (2.5%) developed disseminated intravascular coagulation. Lymphopenia was shown in haemato-lymphoid organs at postmortem examination. Multivariate analysis showed that advanced age and a high concentration of lactate dehydrogenase at presentation were independent predictors of an adverse outcome. Subsets of peripheral blood lymphocytes were analysed in 31 patients. The counts of CD4 positive and CD8 positive T cells fell early in the course of illness. Low counts of CD4 and CD8 cells at presentation were associated with adverse outcomes.
Conclusions: Abnormal haematological variables were common among patients with SARS. Lymphopenia and the depletion of T lymphocyte subsets may be associated with disease activity.
Figures






Comment in
-
SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS.BMJ. 2003 Sep 13;327(7415):620. doi: 10.1136/bmj.327.7415.620-b. BMJ. 2003. PMID: 12969939 Free PMC article. No abstract available.
-
Real time assay of Aspergillus should be used in SARS patients receiving corticosteroids.BMJ. 2003 Dec 13;327(7428):1405. doi: 10.1136/bmj.327.7428.1405. BMJ. 2003. PMID: 14670903 Free PMC article. No abstract available.
References
-
- Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348: 1986-94. - PubMed
-
- Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348: 1953-66. - PubMed
-
- Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, Green K, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348: 1995-2005. - PubMed
-
- Outbreak of severe acute respiratory syndrome--worldwide, 2003. MMWR Morb Mortal Wkly Rep 2003;52: 226-8. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous